Mount Sinai Health System prioritizes the value of AI beyond just financial gain, with a unique leadership structure and focus on ethical implementation.
Mount Sinai, which posted operating revenue of $10.8 billion in 2023, has been aggressively pursuing both administrative and clinical AI applications. Late last year, the hospital christened the $ ...
During the third quarter of fiscal year 2025 (“Q3 FY2025”) and to date in 2025, HeartSciences has seen material progress towards FDA submissions of our products and there have been significant ...
As health care costs continue to rise and the burden of chronic disease grows, data-driven insights will be essential in ...
As healthcare organizations seek to improve efficiency and accuracy in medical coding, many are exploring AI-driven solutions ...
In response, Cogito Tech has launched DataSum, a certification framework designed to make AI data sourcing more transparent ...
HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused ...
The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.
About the Mount Sinai Global Surgery Program The Mount Sinai ... audiovisual capabilities, AI, and machine learning to elevate patient safety, optimize operations, and facilitate continuous ...
Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback